IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.468
EU - Europa 4.382
AS - Asia 2.423
SA - Sud America 671
Continente sconosciuto - Info sul continente non disponibili 338
AF - Africa 70
Totale 12.352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.291
RU - Federazione Russa 2.112
SG - Singapore 1.036
CN - Cina 621
IT - Italia 605
BR - Brasile 555
IE - Irlanda 486
HK - Hong Kong 299
SE - Svezia 284
DE - Germania 207
FR - Francia 146
PL - Polonia 143
FI - Finlandia 138
VN - Vietnam 134
GB - Regno Unito 101
IN - India 100
CA - Canada 79
BD - Bangladesh 61
AR - Argentina 44
MX - Messico 37
AT - Austria 27
NL - Olanda 26
TR - Turchia 26
ID - Indonesia 25
EC - Ecuador 23
LT - Lituania 22
JP - Giappone 20
BE - Belgio 19
MA - Marocco 16
UA - Ucraina 16
ZA - Sudafrica 16
PK - Pakistan 14
VE - Venezuela 13
UZ - Uzbekistan 12
ES - Italia 11
CI - Costa d'Avorio 10
CO - Colombia 10
CR - Costa Rica 9
IQ - Iraq 9
MY - Malesia 8
PE - Perù 8
PH - Filippine 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CL - Cile 7
JM - Giamaica 7
KE - Kenya 7
NI - Nicaragua 7
CZ - Repubblica Ceca 6
GT - Guatemala 6
HN - Honduras 6
NP - Nepal 6
RO - Romania 6
PR - Porto Rico 5
PY - Paraguay 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
EE - Estonia 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
UG - Uganda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
Totale 12.010
Salva come PNG Salva come JPEG
Città #
Ashburn 905
Moscow 673
Singapore 546
Dublin 482
Dallas 390
San Jose 322
Chandler 320
Hong Kong 295
Nyköping 214
Beijing 204
Messina 195
Council Bluffs 154
Warsaw 139
Munich 133
The Dalles 111
Los Angeles 91
Lauterbourg 75
Princeton 72
Helsinki 70
Medford 63
Santa Clara 51
Ann Arbor 50
Des Moines 49
New York 46
Buffalo 43
Ho Chi Minh City 41
São Paulo 39
Jacksonville 38
Tianjin 36
Pune 30
Turku 30
Brooklyn 29
Phoenix 29
Wilmington 29
Chicago 26
Dearborn 25
Rome 25
Bremen 24
Orem 23
Palermo 22
Redondo Beach 22
Seattle 22
Lappeenranta 21
London 21
Chennai 20
Hyderabad 20
Belo Horizonte 19
Cambridge 19
Guangzhou 19
Lawrenceville 19
Milan 19
San Francisco 19
Hanoi 18
Houston 18
Montreal 18
Nuremberg 18
Atlanta 17
Rio de Janeiro 17
Columbus 16
Frankfurt am Main 16
Jinan 16
Tokyo 16
Boardman 15
Brussels 15
Vilnius 15
Mercer Island 14
Redwood City 14
Vienna 14
Brasília 13
Curitiba 13
Denver 13
Shanghai 13
Boston 12
Duncan 12
Falls Church 12
Mexico City 12
Tashkent 12
Toronto 12
Amsterdam 11
Catania 11
Guayaquil 11
Jakarta 11
Abidjan 10
Carrboro 10
North Bergen 10
Porto Alegre 10
Zhengzhou 10
Poplar 9
San José 9
Campinas 8
Changsha 8
Dong Ket 8
Johannesburg 8
Ningbo 8
Shenyang 8
Shenzhen 8
Baku 7
Da Nang 7
Istanbul 7
Livorno 7
Totale 6.956
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 375
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 352
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 345
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 271
A Nouvel serum MicroRNA signature to screen ATTR 238
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 228
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 227
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 210
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 204
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 202
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 188
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 186
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 183
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 181
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 179
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 178
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 176
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 172
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 165
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 162
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 162
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 162
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 158
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 149
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 142
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 140
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 138
Considerable post-partum worsening in a patient with CMT2E 137
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 137
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 137
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 136
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 136
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 135
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 133
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 131
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 131
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 127
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 126
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 123
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 122
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 122
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 122
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 121
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 117
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 117
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 116
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 116
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 116
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 113
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 113
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 113
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 112
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 112
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 109
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 107
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 106
Impact of environmental factors and physical activity on disability and quality of life in CIDP 106
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 105
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 103
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 102
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 101
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 101
The THAOS: record of patients from our site. 101
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 101
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 99
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 98
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 97
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 97
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 96
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 95
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 94
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 94
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 91
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 88
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 87
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 87
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 86
(TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 86
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 85
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 79
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 76
Rare among rare: Phenotypes of uncommon CMT genotypes 75
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 74
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 74
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 67
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 66
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 62
null 54
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 50
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy 43
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 40
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 39
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 37
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 33
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 31
Phenotype-Genotype Correlations in Early-Onset Myelin Protein Zero–Related Neuropathies 30
null 30
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 28
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 28
The neurophysiological lesson from the Italian CIDP database 27
Totale 12.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022404 0 0 0 16 39 11 47 28 16 22 31 194
2022/20231.267 105 115 77 76 86 114 18 61 562 13 25 15
2023/2024392 27 54 21 27 32 107 16 32 5 25 6 40
2024/20252.205 72 22 48 141 137 141 202 312 441 124 212 353
2025/20265.801 321 462 434 357 478 1.147 682 699 642 299 129 151
2026/20271.284 221 273 281 509 0 0 0 0 0 0 0 0
Totale 12.352